Aligos Therapeutics, Inc. (ALGS) — Institutional Holders, Q2 2026

31 institutional investment managers reported a ALGS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $13.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ALGS in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

5

Added to

7

Trimmed

7

Sold out

8

Biggest buyers

  1. D. E. ShawAdded · +55,485 sh+$320.1K
  2. JANE STREET GROUPNew · +32,402 sh+$187.0K
  3. UBS Group AGAdded · +22,925 sh+$132.3K
  4. DIMENSIONAL FUND ADVISORSNew · +21,044 sh+$121.4K
  5. BlackRockAdded · +17,252 sh+$99.5K

Biggest sellers

  1. BANK OF AMERICASold out · -229,754 sh-$1.3M
  2. SummitTX Capital, L.P.Sold out · -148,799 sh-$858.6K
  3. RENAISSANCE TECHNOLOGIESTrimmed · -89,650 sh-$517.3K
  4. CITADEL ADVISORSSold out · -54,311 sh-$313.4K
  5. LPL FinancialSold out · -51,500 sh-$297.2K

ALGS 13F holders ranked 1–31 of 31

Institutional investors reporting a position in Aligos Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Deep Track Capital#1 · 444,110 sh$2.6M0.0%
Alyeska Investment Group, L.P.#2 · 412,000 sh$2.4M0.0%
Sio Capital Management#3 · 327,237 sh$1.9M0.0%
MARSHALL WACE, LLP#4 · 246,579 sh$1.4M-7.7%
Woodline Partners#5 · 177,362 sh$1.0M0.0%
VANGUARD CAPITAL MANAGEMENT#6 · 175,543 sh$1.0M-1.5%
BAKER BROS. ADVISORS#7 · 83,055 sh$479.2K0.0%
Hillhouse Capital Advisors, Ltd.#8 · 76,247 sh$439.9K0.0%
D. E. Shaw#9 · 66,463 sh$383.5K+505.4%
UBS Group AG#10 · 59,986 sh$346.1K+61.9%
GEODE CAPITAL MANAGEMENT#11 · 47,173 sh$272.3K-5.6%
JANE STREET GROUP#12 · 32,402 sh$187.0KNew
BlackRock#13 · 30,292 sh$174.8K+132.3%
VANGUARD FIDUCIARY#14 · 28,612 sh$165.1K+0.6%
DIMENSIONAL FUND ADVISORS#15 · 21,044 sh$121.4KNew
Verition Fund Management#16 · 18,887 sh$109.0K0.0%
Trexquant Investment#17 · 12,339 sh$71.2KNew
RENAISSANCE TECHNOLOGIES#18 · 10,800 sh$62.3K-89.2%
Rockefeller Capital Management L.P.#19 · 10,000 sh$57.7K0.0%
Federation des caisses Desjardins du Quebec#20 · 4,650 sh$26.8K+389.5%
Golden State Wealth Management#21 · 2,674 sh$15.4K0.0%
ROYAL BANK OF CANADA#22 · 2,125 sh$12.0K0.0%
CITIGROUP#23 · 1,808 sh$10.4KNew
Tower Research Capital (TRC)#24 · 359 sh$2.1K+452.3%
JPMORGAN CHASE#25 · 344 sh$1.9K-49.0%
MORGAN STANLEY#26 · 204 sh$1.2K-6.4%
SBI Securities , Ltd.#27 · 126 sh$727.00+384.6%
WELLS FARGO & COMPANY#28 · 100 sh$577.00-85.7%
FMR#29 · 10 sh$58.00New
ZRC WEALTH MANAGEMENT#30 · 4 sh$24.000.0%
BNP PARIBAS FINANCIAL MARKETS#31 · 3 sh$17.000.0%

Funds that sold out of ALGS in Q2 2026 (8)

Held ALGS at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held ALGS in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
BANK OF AMERICA229,754 sh$1.7M
SummitTX Capital, L.P.148,799 sh$1.1M
CITADEL ADVISORS54,311 sh$403.5K
LPL Financial51,500 sh$382.6K
TWO SIGMA INVESTMENTS23,093 sh$171.6K
XTX Topco Ltd14,196 sh$105.5K
Quadrature Capital Ltd10,822 sh$80.4K
Vanguard Global Advisers936 sh$7.0K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.